生物素对现行及新配方Beckman甲状腺球蛋白检测的影响
该研究探讨生物素对现行Access甲状腺球蛋白检测的干扰及Beckman新配方检测的抗干扰能力。通过血清池添加生物素及3名志愿者口服10 mg生物素前后对比,发现现行检测在生物素存在下结果显著降低,而新配方检测无显著变化。结论为新配方甲状腺球蛋白检测不受生物素干扰。
要点
- 现行Beckman甲状腺球蛋白检测受生物素负干扰,结果显著降低。
- 新配方Beckman甲状腺球蛋白检测不受生物素干扰。
- 口服10 mg生物素后2小时,现行检测结果显著降低,新配方无显著变化。
核心结论
- Beckman新配方甲状腺球蛋白检测不受生物素干扰。
研究设计与样本
- 体外实验:4份含不同甲状腺球蛋白量的血清池,分别添加不同量生物素,用现行和新配方检测测定甲状腺球蛋白浓度。
- 体内实验:3名志愿者口服10 mg生物素,服药前和服药后2小时采血,用两种检测测定甲状腺球蛋白浓度。
主要发现
- 在有生物素存在时,现行检测的甲状腺球蛋白浓度显著降低。
- 新配方检测在生物素存在时甲状腺球蛋白浓度无显著变化。
- 体内实验观察到与体外实验相似的结果。
临床怎么用
- 对于使用Beckman甲状腺球蛋白检测的患者,若存在生物素摄入,应关注现行检测的负干扰风险。
- 可选用新配方甲状腺球蛋白检测以避免生物素干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Biotin causes negative interference with thyroglobulin measurement using the Access thyroglobulin assay. Recently, Beckman reformulated the thyroglobulin assay to overcome biotin interference. We investigated the effect of biotin on both current and newly formulated assays. METHODS: Four serum pools were prepared using specimens containing various amounts of thyroglobulin. Then aliquots of each pool were supplemented with various amounts of biotin, and thyroglobulin concentrations were measured by both the current and the new assays. In addition, 3 volunteers ingested 10 mg biotin, and specimens were drawn before and 2 hours after taking biotin. Thyroglobulin concentrations before and 2 hours after taking biotin were measured by both assays. RESULTS: In the presence of biotin, thyroglobulin concentrations were reduced significantly using the current assay, but no significant change was observed using the newly formulated assay. We observed similar results in vivo. CONCLUSIONS: The newly formulated thyroglobulin assay by Beckman is free from biotin interference.
引用
- Countryman B, McBride M, McCracken T, et al. Effect of biotin on currently used Beckman thyroglobulin assay and newly reformulated thyroglobulin assay not affected by biotin. Am J Clin Pathol. 2024. PMID: 38682538. doi:10.1093/ajcp/aqae048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。